Abstract
The neuraminiclase inhibitors (NAIs) are an effective class of antiviral drugs for the treatment of influenza A and B infections. Until recently, only a low prevalence of NAI resistance (
Original language | English |
---|---|
Pages (from-to) | 90-93 |
Journal | Antiviral Research |
Volume | 83 |
DOIs | |
Publication status | Published - 2009 |